BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 31561043)

  • 1. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.
    Tripathi A; Choubey PK; Sharma P; Seth A; Tripathi PN; Tripathi MK; Prajapati SK; Krishnamurthy S; Shrivastava SK
    Eur J Med Chem; 2019 Dec; 183():111707. PubMed ID: 31561043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
    Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
    Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Molecular Hybrids of
    Sharma P; Tripathi A; Tripathi PN; Singh SS; Singh SP; Shrivastava SK
    ACS Chem Neurosci; 2019 Oct; 10(10):4361-4384. PubMed ID: 31491074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.
    Sharma P; Tripathi A; Tripathi PN; Prajapati SK; Seth A; Tripathi MK; Srivastava P; Tiwari V; Krishnamurthy S; Shrivastava SK
    Eur J Med Chem; 2019 Apr; 167():510-524. PubMed ID: 30784883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease.
    Choubey PK; Tripathi A; Tripathi MK; Seth A; Shrivastava SK
    Bioorg Chem; 2021 Jun; 111():104922. PubMed ID: 33945941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease.
    Choubey PK; Tripathi A; Sharma P; Shrivastava SK
    Bioorg Med Chem; 2020 Nov; 28(22):115721. PubMed ID: 33007563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions.
    Tripathi PN; Srivastava P; Sharma P; Seth A; Shrivastava SK
    Bioorg Med Chem; 2019 Apr; 27(7):1327-1340. PubMed ID: 30795991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy.
    Verma A; Waiker DK; Singh N; Roy A; Singh N; Saraf P; Bhardwaj B; Krishnamurthy S; Trigun SK; Shrivastava SK
    ACS Chem Neurosci; 2024 Feb; 15(4):745-771. PubMed ID: 38327209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and development of 1,3,4-oxadiazole derivatives as potential inhibitors of acetylcholinesterase to ameliorate scopolamine-induced cognitive dysfunctions.
    Mishra P; Sharma P; Tripathi PN; Gupta SK; Srivastava P; Seth A; Tripathi A; Krishnamurthy S; Shrivastava SK
    Bioorg Chem; 2019 Aug; 89():103025. PubMed ID: 31176239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
    Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis, and Biological Evaluation of Piperazine and
    Waiker DK; Verma A; Akhilesh ; A GT; Singh N; Roy A; Dilnashin H; Tiwari V; Trigun SK; Singh SP; Krishnamurthy S; Lama P; Davisson VJ; Shrivastava SK
    ACS Chem Neurosci; 2023 Jun; 14(11):2217-2242. PubMed ID: 37216500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
    Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
    Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological activity of novel donepezil derivatives bearing N-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors.
    Lan JS; Zhang T; Liu Y; Yang J; Xie SS; Liu J; Miao ZY; Ding Y
    Eur J Med Chem; 2017 Jun; 133():184-196. PubMed ID: 28388521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of new coumarin-dithiocarbamate hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Jiang N; Huang Q; Liu J; Liang N; Li Q; Li Q; Xie SS
    Eur J Med Chem; 2018 Feb; 146():287-298. PubMed ID: 29407958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
    Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
    Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
    Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
    Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
    Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.